Structures by: Jasinski J. P.
Total: 594
(2E)-1-(3-Hydroxyphenyl)-3-(4-methylphenyl)prop-2-en-1-one
C16H14O2
Acta Crystallographica Section E (2007) 63, 8 o3660-o3660
a=7.6363(5)Å b=11.0786(5)Å c=15.2355(8)Å
α=90.00° β=104.038(6)° γ=90.00°
(2E)-3-(4-Chlorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11ClO2
Acta Crystallographica Section E (2007) 63, 8 o3661-o3661
a=7.5910(7)Å b=10.8509(7)Å c=15.1544(11)Å
α=90.00° β=104.213(8)° γ=90.00°
7-Hydroxy-4-methyl-2<i>H</i>-chromen-2-one monohydrate
C10H8O3,H2O
Acta Crystallographica Section E (2007) 63, 8 o3412-o3413
a=6.9508(5)Å b=11.3074(8)Å c=11.7833(8)Å
α=90.00° β=105.6430(10)° γ=90.00°
2,4-Diacetylquinoline
C13H11NO2
Acta Crystallographica Section E (2007) 63, 8 o3557-o3557
a=7.5285(6)Å b=15.0366(12)Å c=9.7202(7)Å
α=90.00° β=105.704(9)° γ=90.00°
(2E)-3-(4-Fluorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11FO2
Acta Crystallographica Section E (2007) 63, 8 o3586-o3586
a=7.4149(4)Å b=11.3162(6)Å c=14.7472(8)Å
α=90.00° β=104.311(6)° γ=90.00°
1-(Quinolin-2-yl)ethanone
C11H9NO
Acta Crystallographica Section E (2007) 63, 8 o3603-o3603
a=10.3292(4)Å b=24.1165(9)Å c=15.0923(5)Å
α=90.00° β=109.7820(10)° γ=90.00°
{Tris[2-(imidazol-2-ylmethylimino)ethyl]methylammonium}iron(II) tris(perchlorate) dihydrate
C19H27FeN103,3(ClO4),2(H2O)
Acta Crystallographica Section E (2008) 64, 1 m1-m1
a=13.9630(18)Å b=11.7810(15)Å c=37.182(5)Å
α=90° β=90° γ=90°
Β-Arteether
C17H28O5
Acta Crystallographica Section E (2008) 64, 3 o585-o586
a=10.0253(6)Å b=10.0253(6)Å c=28.628(3)Å
α=90.00° β=90.00° γ=120.00°
3,5-Bis(4-fluorophenyl)-1-phenyl-1<i>H</i>-pyrazole
C21H14F2N2
Acta Crystallographica Section C (2014) 70, 9
a=31.729(2)Å b=10.4118(7)Å c=10.1697(6)Å
α=90° β=97.700(7)° γ=90°
(5<i>RS</i>,6<i>SR</i>)-6-(4-Fluorobenzoyl)-5-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5,6-dihydro-4<i>H</i>-1,3,4-oxadiazine <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C22H16F2N2O3,C3H7NO
Acta Crystallographica Section C (2014) 70, 9
a=17.5182(7)Å b=7.4306(3)Å c=17.5595(7)Å
α=90° β=101.252(4)° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-fluorophenyl)-2,4-bis(pyridine-2-carbonyl)1-(pyridin-2-yl)cyclohexanol
C35H27F2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=21.8864(9)Å b=11.2268(4)Å c=24.2670(9)Å
α=90° β=90° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)- 3,5-Bis(4-bromophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol
C35H27Br2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=9.5741(4)Å b=10.7061(3)Å c=15.9952(6)Å
α=92.863(3)° β=97.443(3)° γ=103.618(3)°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-chlorophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol acetone 0.951-solvate
C35H27Cl2N3O3,0.951(C3H6O)
Acta Crystallographica Section C (2014) 70, 10 953-959
a=16.5446(6)Å b=53.4204(17)Å c=15.5857(4)Å
α=90° β=90° γ=90°
4-[1-(2-Hydroxypropyl)-4,5-diphenyl-1<i>H</i>-imidazol-2-yl]benzoic acid
C25H22N2O3
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o77
a=6.8710(4)Å b=10.7188(6)Å c=14.9178(7)Å
α=103.569(4)° β=93.094(4)° γ=105.878(5)°
(<i>Z</i>)-2,2',4,4',5,5'-Hexamethoxystilbene
C20H24O6
Acta Crystallographica Section C (2015) 71, 6
a=17.0340(7)Å b=5.0747(2)Å c=22.6111(10)Å
α=90° β=110.917(5)° γ=90°
Triphenyl(3,4,5-trimethoxybenzyl)phosphonium chloride monohydrate
C28H28O3P,Cl,H2O
Acta Crystallographica Section C (2015) 71, 6
a=14.5660(4)Å b=15.8567(3)Å c=11.0472(3)Å
α=90° β=104.872(3)° γ=90°
C14H15N1O2
C14H15N1O2
Acta Crystallographica Section C (1995) 51, 107-109
a=21.937(8)Å b=15.327(3)Å c=6.9240(10)Å
α=90° β=90° γ=90°
C14H15N1O2
C14H15N1O2
Acta Crystallographica Section C (1995) 51, 107-109
a=8.779(2)Å b=22.042(5)Å c=6.043(2)Å
α=90° β=90° γ=90°
7-Hydroxy-4-methylcoumarin monohydrate
C10H8O3,H2O
Acta Crystallographica Section C (1994) 50, 12 1952-1953
a=7.106(2)Å b=11.335(2)Å c=11.817(2)Å
α=90° β=105.300(10)° γ=90°
7-Amino-4-methylcoumarin
C10H9NO2
Acta Crystallographica Section C (1994) 50, 12 1954-1956
a=7.1570(10)Å b=9.5660(10)Å c=6.9200(10)Å
α=95.130(10)° β=110.110(10)° γ=71.780(10)°
C12H10F3NO2
C12H10F3NO2
Acta Crystallographica Section C (1994) 50, 12 1928-1930
a=7.2796(7)Å b=15.755(2)Å c=9.8340(10)Å
α=90° β=91.087(9)° γ=90°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetrabenzyl-<i>N</i>''-(2-chloro- 2,2-difluoroacetyl)phosphoric triamide
C30H29ClF2N3O2P
Acta Crystallographica Section C (2012) 68, 10 o399-o404
a=10.8298(3)Å b=9.9164(3)Å c=26.6740(8)Å
α=90.00° β=91.5390(10)° γ=90.00°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetrabenzyl-<i>N</i>''-(3- fluorobenzoyl)phosphoric triamide
C35H33FN3O2P
Acta Crystallographica Section C (2012) 68, 10 o399-o404
a=10.0173(10)Å b=11.2362(8)Å c=14.5992(12)Å
α=99.351(6)° β=109.960(8)° γ=91.135(7)°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetrabenzyl-<i>N</i>''-(3,5- difluorobenzoyl)phosphoric triamide
C35H32F2N3O2P
Acta Crystallographica Section C (2012) 68, 10 o399-o404
a=11.9526(11)Å b=12.2897(10)Å c=12.7463(12)Å
α=102.074(7)° β=104.462(8)° γ=118.262(9)°
C24H19NO
C24H19NO
Acta Crystallographica Section C (2000) 56, 3 386-388
a=10.405(2)Å b=11.524(2)Å c=9.177(2)Å
α=113.440(10)° β=113.94(2)° γ=93.94(2)°
C24H19NO
C24H19NO
Acta Crystallographica Section C (2000) 56, 3 386-388
a=9.9560(10)Å b=11.329(2)Å c=8.939(2)Å
α=109.890(10)° β=107.060(10)° γ=69.470(10)°
Methyl 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oate
C32H43NO4,CH4O,H2O
Acta Crystallographica Section C (2002) 58, 3 o199-o200
a=6.5370(10)Å b=8.9500(10)Å c=51.128(9)Å
α=90° β=90° γ=90°
C30H24N2O2S
C30H24N2O2S
Acta Crystallographica Section C (2000) 56, 4 461-462
a=10.3000(10)Å b=13.3900(10)Å c=9.322(7)Å
α=105.65(9)° β=98.62(9)° γ=88.45(3)°
Cis-Tetracarbonyl[bis(tricyclohexylphosphine)]molybdenum(0)
C40H66MoO4P2
Acta Crystallographica Section C (2000) 56, 12 1435-1437
a=10.856(3)Å b=25.323(8)Å c=14.795(7)Å
α=90.00° β=94.68(3)° γ=90.00°
Pentacarbonyl(tricyclohexylphosphine)molybdenum(0)
C23H33MoO5P
Acta Crystallographica Section C (2000) 56, 12 1435-1437
a=11.785(3)Å b=16.760(7)Å c=12.779(4)Å
α=90.00° β=92.15(2)° γ=90.00°
(<i>E</i>)-2-[(2-Hydroxy-5-nitrophenyl)iminiomethyl]phenolate
C13H10N2O4
Acta Crystallographica Section E (2009) 65, 3 o490-o491
a=7.3949(3)Å b=9.1058(4)Å c=17.2734(6)Å
α=90.00° β=96.387(4)° γ=90.00°
2-Bromo-<i>N</i>'-[(2<i>Z</i>)-butan-2-ylidene]-5-methoxybenzohydrazide
C12H15BrN2O2
Acta Crystallographica Section E (2009) 65, 11 o2968-o2969
a=8.09420(10)Å b=14.2475(2)Å c=11.2974(2)Å
α=90.00° β=91.1519(13)° γ=90.00°
5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-pyridyl}-2-methylpyridinium 2,4,6-trinitrophenolate
C18H16ClN2O2S,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o107-o108
a=9.02500(10)Å b=12.74960(10)Å c=21.8011(3)Å
α=90.00° β=98.1140(10)° γ=90.00°
Enrofloxacinium picrate
C19H23FN3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o432-o433
a=7.2111(7)Å b=12.5766(7)Å c=16.2362(4)Å
α=105.556(2)° β=96.367(6)° γ=96.223(7)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H11ClN2O
Acta Crystallographica Section E (2009) 65, 8 o1987-o1988
a=4.2546(4)Å b=11.6274(10)Å c=20.604(2)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-nitrophenyl 2-chlorophenyl ketone
C13H9ClN2O3
Acta Crystallographica Section E (2009) 65, 8 o1908-o1909
a=10.6120(3)Å b=11.3314(3)Å c=10.8456(3)Å
α=90.00° β=108.399(3)° γ=90.00°
(2<i>E</i>)-1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17FO4
Acta Crystallographica Section E (2009) 65, 8 o1965-o1966
a=12.4250(2)Å b=8.62800(10)Å c=14.9038(2)Å
α=90.00° β=98.3217(12)° γ=90.00°
6-{[(Benzyloxy)carbonyl]oxy}-2-methylhexahydropyrano[3,2-<i>d</i>][1,3]dioxin-7,8-diyl bis(chloroacetate)
C20H22Cl2O10
Acta Crystallographica Section E (2010) 66, 3 o572-o573
a=8.17800(10)Å b=14.9165(3)Å c=19.3555(4)Å
α=90.00° β=90.00° γ=90.00°
7-(4-Chlorophenyl)-9-phenyl-7<i>H</i>-pyrrolo[3,2-<i>e</i>]tetrazolo[1,5-<i>c</i>]pyrimidine
C18H11ClN6
Acta Crystallographica Section E (2010) 66, 3 o601-o602
a=11.8335(3)Å b=17.4200(5)Å c=7.4094(2)Å
α=90.00° β=91.1290(10)° γ=90.00°
Lansoprazole intermediate--chloranilic acid (2:1)
2(C16H15F3N3OS),C6Cl2O42
Acta Crystallographica Section E (2010) 66, 6 o1507-o1508
a=9.48575(8)Å b=23.6316(2)Å c=17.86775(15)Å
α=90.00° β=100.2065(9)° γ=90.00°
Tris(ethane-1,2-diamine-κ^2^<i>N</i>,<i>N</i>)cobalt(III) carbonate iodide tetrahydrate
C6H24CoN63,CO3,I,4(H2O)
Acta Crystallographica Section E (2010) 66, 9 m1148-m1149
a=16.6907(2)Å b=8.70310(10)Å c=12.5718(2)Å
α=90.00° β=90.00° γ=90.00°
(1<i>E</i>)-1-(3-Bromophenyl)ethanone 2,4-dinitrophenylhydrazone
C14H11BrN4O4
Acta Crystallographica Section E (2010) 66, 11 o2832-o2833
a=7.7546(9)Å b=13.4362(15)Å c=14.1884(16)Å
α=91.894(2)° β=90.553(2)° γ=97.128(2)°
<i>N</i>-[(2-Chloro-3-quinolyl)methyl]-4-fluoroaniline
C16H12ClFN2
Acta Crystallographica Section E (2010) 66, 10 o2548-o2549
a=7.3661(8)Å b=8.8967(9)Å c=11.5129(12)Å
α=68.7040(10)° β=74.4680(10)° γ=75.4450(10)°
2-(4-Chlorophenyl)-6-methoxychroman-4-one
C16H13ClO3
Acta Crystallographica Section E (2010) 66, 10 o2546-o2547
a=5.0188(3)Å b=12.0138(7)Å c=12.3708(7)Å
α=108.035(5)° β=98.379(4)° γ=91.820(5)°
1H-imidazole
C25H16N4
Acta Crystallographica Section E (2011) 67, 4 o989
a=8.8693(7)Å b=10.0637(6)Å c=11.8960(9)Å
α=100.219(6)° β=110.310(7)° γ=102.475(6)°
(2<i>E</i>)-3-(2-Anthracen-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one
C23H16O2
Acta Crystallographica Section E (2011) 67, 4 o795
a=14.0748(5)Å b=13.7362(5)Å c=16.9800(8)Å
α=90.00° β=101.487(5)° γ=90.00°
(2<i>E</i>)-3-{4-[(1<i>H</i>-1,3-Benzimidazol-2-yl)methoxy]-3-ethoxyphenyl}- 1-(4-bromophenyl)prop-2-en-1-one monohydrate
C25H21BrN2O3,H2O
Acta Crystallographica Section E (2011) 67, 4 o834-o835
a=13.8406(12)Å b=16.5192(8)Å c=19.4719(13)Å
α=90.00° β=90.00° γ=90.00°
(3aR,8aR)-2,2,6,6-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-1,3- dioxolo[4,5-<i>e</i>][1,3,2]dioxasilepine
C33H34O4Si
Acta Crystallographica Section E (2009) 65, 1 o135
a=10.008(2)Å b=17.081(3)Å c=17.271(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>'-Bis[(<i>E</i>)-2-fluorobenzylidene]-1-(2- fluorophenyl)methanediamine
C21H15F3N2
Acta Crystallographica Section E (2010) 66, 2 o422-o423
a=8.0215(5)Å b=9.3740(4)Å c=11.9744(6)Å
α=99.184(4)° β=93.179(5)° γ=108.165(5)°
1-(4-Bromophenyl)-3-butanoylthiourea
C11H13BrN2OS
Acta Crystallographica Section E (2011) 67, 1 o46
a=6.1746(3)Å b=10.7883(4)Å c=19.6450(8)Å
α=87.719(3)° β=81.557(4)° γ=76.047(4)°
3-(4-Chlorophenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one
C25H18ClNO
Acta Crystallographica Section E (2011) 67, 3 o621
a=6.5376(2)Å b=10.0345(4)Å c=15.6545(6)Å
α=90.845(3)° β=95.521(3)° γ=107.035(3)°
1-(5-Carboxypentyl)-2,3,3-trimethyl-3<i>H</i>-indol-1-ium bromide monohydrate
C17H24NO2,Br,H2O
Acta Crystallographica Section E (2010) 66, 1 o171-o172
a=14.4528(3)Å b=15.3367(2)Å c=8.0810(2)Å
α=90.00° β=99.437(2)° γ=90.00°
7-(4-Methoxyphenyl)-5-methyl-9-phenyl-7<i>H</i>- pyrrolo[2',3':4,5]pyrimido[1,6-<i>d</i>]tetrazole
C20H16N6O
Acta Crystallographica Section E (2010) 66, 1 o212-o213
a=13.738(2)Å b=7.032(3)Å c=19.4350(3)Å
α=90.00° β=110.217(2)° γ=90.00°
2,4-Dichloro-1-[1-(2,4-dichlorobenzyloxy)ethyl]benzene
C15H12Cl4O
Acta Crystallographica Section E (2010) 66, 1 o165-o166
a=9.3755(4)Å b=9.9229(4)Å c=9.9667(4)Å
α=62.313(3)° β=70.246(4)° γ=71.467(4)°
Ethyl (2<i>Z</i>)-2-(3-methoxybenzylidene)-7-methyl-3-oxo-5-phenyl-2,3-dihydro-\ 5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C24H22N2O4S
Acta Crystallographica Section E (2010) 66, 3 o599-o600
a=33.0445(6)Å b=9.5013(2)Å c=13.8845(2)Å
α=90.00° β=101.5480(10)° γ=90.00°
Desipramine hydrochloride
C18H23N2,Cl
Acta Crystallographica Section E (2010) 66, 3 o674-o675
a=10.7258(3)Å b=15.9997(6)Å c=20.6088(8)Å
α=107.347(3)° β=89.960(2)° γ=99.414(2)°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one
C15H10Br2O
Acta Crystallographica Section E (2010) 66, 7 o1701
a=5.6988(5)Å b=9.5462(9)Å c=23.8532(15)Å
α=90.00° β=91.021(8)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17BrO4
Acta Crystallographica Section E (2010) 66, 7 o1676
a=9.9616(4)Å b=13.6020(13)Å c=24.4162(17)Å
α=90.00° β=90.00° γ=90.00°
4-Phenylsulfonyl-2-(<i>p</i>-tolylsulfonyl)-1<i>H</i>,8<i>H</i>- pyrrolo[2,3-<i>b</i>]indole
C23H18N2O4S2
Acta Crystallographica Section E (2010) 66, 11 o2757-o2758
a=8.1547(3)Å b=11.0471(5)Å c=11.7185(4)Å
α=73.834(4)° β=87.131(3)° γ=79.277(4)°
Cinnarizinium dipicrate
C26H30N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o500-o501
a=15.1987(2)Å b=10.09130(17)Å c=25.0724(3)Å
α=90.00° β=95.9170(14)° γ=90.00°
(<i>RS</i>)-4-(3-carboxy-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinolin-7-yl)- 2-methylpiperazin-1-ium 2,4,6-trinitrophenolate
C17H20F2N3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o483-o484
a=10.9314(4)Å b=11.6748(4)Å c=12.0530(4)Å
α=92.969(3)° β=115.555(3)° γ=109.852(3)°
Ethyl 2-(4-nitrobenzamido)benzoate
C16H14N2O5
Acta Crystallographica Section E (2011) 67, 2 o465
a=6.9802(3)Å b=9.3570(4)Å c=12.5779(5)Å
α=102.833(4)° β=94.296(4)° γ=107.567(4)°
Ethylenediammonium dipicrate dihydrate
C2H10N22,2(C6H2N3O7),2(H2O)
Acta Crystallographica Section E (2011) 67, 3 o637-o638
a=13.4795(4)Å b=20.4372(7)Å c=8.0410(3)Å
α=90.00° β=90.00° γ=90.00°
4-[(<i>E</i>)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidinium picrate
C12H15F2N2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2365-o2366
a=6.0926(4)Å b=13.5364(8)Å c=24.0417(14)Å
α=90.00° β=92.671(6)° γ=90.00°
3-(2,6-Dioxopiperidin-3-yl)-3-azabicyclo[3.2.0]heptane-2,4-dione
C11H12N2O4
Acta Crystallographica Section E (2009) 65, 2 o394-o395
a=10.7332(7)Å b=9.9358(5)Å c=11.0753(7)Å
α=90.00° β=116.201(8)° γ=90.00°
(<i>E</i>)-2-[(2-Hydroxy-5-nitrophenyl)iminiomethyl]-4-nitrophenolate
C13H9N3O6
Acta Crystallographica Section E (2009) 65, 2 o291-o292
a=7.96490(10)Å b=8.61100(10)Å c=19.1190(3)Å
α=90.00° β=98.433(2)° γ=90.00°
(<i>E</i>)-2-{(2-Hydroxynaphthalen-1-yl)methylene}hydrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section E (2009) 65, 5 o1111-o1112
a=16.0886(4)Å b=4.72900(10)Å c=15.6452(4)Å
α=90.00° β=114.647(3)° γ=90.00°
4-(2,2-Diphenyl-2-propoxyacetoxy)-1-methylpiperidin-1-ium picrate
C23H30NO3,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 8 o1738-o1739
a=8.9379(4)Å b=9.2885(4)Å c=18.0750(7)Å
α=97.652(3)° β=97.630(3)° γ=104.301(4)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>] pyrimidinium-4-one picrate
C11H12ClN2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 9 o2201-o2202
a=7.2718(5)Å b=12.8159(9)Å c=19.940(3)Å
α=90.00° β=97.642(9)° γ=90.00°
Haloperidol picrate
C21H24ClFNO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2403-o2404
a=14.9089(5)Å b=12.5934(3)Å c=14.5074(5)Å
α=90.00° β=90.00° γ=90.00°
1-(2-methyl-5-nitrophenyl)guanidinium picrate
C8H11N4O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 11 o2788-o2789
a=7.1318(10)Å b=10.6239(13)Å c=11.9564(13)Å
α=84.257(10)° β=74.497(11)° γ=77.559(11)°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10Cl2O
Acta Crystallographica Section E (2009) 65, 11 o2641-o2642
a=5.8884(9)Å b=7.3328(9)Å c=14.6752(16)Å
α=102.821(10)° β=95.003(10)° γ=92.933(11)°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 1 o158
a=5.9197(8)Å b=7.3391(11)Å c=14.8171(17)Å
α=101.929(11)° β=94.371(10)° γ=93.299(11)°
<i>N</i>-(3,4-Dichlorophenyl)-3-oxobutanamide
C10H9Cl2NO2
Acta Crystallographica Section E (2010) 66, 1 o58-o59
a=9.7171(4)Å b=8.2834(5)Å c=27.4857(16)Å
α=90.00° β=90.00° γ=90.00°
6,11-Dihydrodibenz[<i>b</i>,<i>e</i>]oxepin-11-one
C14H10O2
Acta Crystallographica Section E (2010) 66, 1 o159-o160
a=16.5065(18)Å b=4.0806(7)Å c=15.0392(17)Å
α=90.00° β=93.654(10)° γ=90.00°
Gabapentin-lactum--chloranilic acid (1/1)
C9H15NO,C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 1 o163-o164
a=6.6127(9)Å b=9.5800(11)Å c=13.0724(13)Å
α=102.679(9)° β=91.934(9)° γ=98.481(10)°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-phenylprop-2-en-1-one
C15H11ClO
Acta Crystallographica Section E (2010) 66, 1 o157
a=5.8388(7)Å b=7.5975(11)Å c=13.1300(16)Å
α=83.182(11)° β=89.422(10)° γ=86.662(11)°
11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[<i>b</i>,<i>e</i>]thiepin- 11-ol
C19H23NOS
Acta Crystallographica Section E (2010) 66, 1 o161-o162
a=7.7215(4)Å b=15.3729(10)Å c=27.9274(16)Å
α=90.00° β=95.401(6)° γ=90.00°
Tris(ethane-1,2-diamine-κ^2^<i>N</i>,<i>N</i>)nickel(II) diiodide
C6H24N6Ni2,2(I)
Acta Crystallographica Section E (2010) 66, 1 m103-m104
a=14.7502(6)Å b=13.4881(4)Å c=15.9624(7)Å
α=90.00° β=90.00° γ=90.00°
Dibenzo[<i>b</i>,<i>e</i>]thiepin-11(6<i>H</i>)-one
C14H10OS
Acta Crystallographica Section E (2010) 66, 2 o350
a=14.6208(11)Å b=4.3503(3)Å c=16.9023(13)Å
α=90.00° β=90.00° γ=90.00°
Chlorimipraminium picrate
C19H24ClN2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 2 o347-o348
a=11.2252(3)Å b=13.1514(3)Å c=17.2787(4)Å
α=90.9414(19)° β=91.1253(19)° γ=100.4446(19)°
Imatinibium dipicrate
C29H33N7O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 2 o411-o412
a=8.560000Å b=10.734000Å c=23.060000Å
α=96.74(3)° β=92.69(2)° γ=101.46(7)°
1-(1,3-Benzodioxol-5-yl)ethanone
C9H8O3
Acta Crystallographica Section E (2010) 66, 2 o383
a=9.4697(3)Å b=10.8445(3)Å c=7.5148(3)Å
α=90.00° β=105.973(3)° γ=90.00°
1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 2 o269-o270
a=15.6695(7)Å b=14.1235(8)Å c=5.8455(3)Å
α=90.00° β=90.771(5)° γ=90.00°
<i>N</i>-(5-Amino-2-methylphenyl)-4-(3-pyridyl)pyrimidin-2-amine
C16H15N5
Acta Crystallographica Section E (2010) 66, 2 o349
a=9.2242(3)Å b=12.5399(4)Å c=12.8594(4)Å
α=72.719(3)° β=89.724(3)° γ=77.712(3)°
3-(10,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)- <i>N</i>,<i>N</i>,2-trimethylpropan-1-aminium hydrogen maleate
C20H27N2,C4H3O4
Acta Crystallographica Section E (2010) 66, 2 o366-o367
a=19.4356(4)Å b=11.0542(4)Å c=40.4107(13)Å
α=90.00° β=90.00° γ=90.00°
7-(4-Bromophenyl)-9-phenyl-7<i>H</i>-pyrrolo[3,2-<i>e</i>]tetrazolo[1,5-<i>c</i>]pyrimidine
C18H11BrN6
Acta Crystallographica Section E (2010) 66, 3 o574
a=12.0173(5)Å b=17.4007(7)Å c=7.4201(4)Å
α=90.00° β=91.004(4)° γ=90.00°
2-Amino-4-methoxy-6-methylpyrimidin-1-ium picrate
C6H10N3O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1189-o1190
a=8.9442(3)Å b=6.2793(3)Å c=27.0354(8)Å
α=90.00° β=94.471(3)° γ=90.00°
5,7-Dimethyl-2,3-dihydro-1<i>H</i>-1,4-diazepin-4-ium picrate
C7H13N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1187-o1188
a=7.2341(3)Å b=27.6458(6)Å c=8.2831(3)Å
α=90.00° β=110.611(4)° γ=90.00°
5α-androstane-3,17-dione
C19H28O2
Acta Crystallographica Section E (2010) 66, 6 o1517-o1518
a=12.7786(6)Å b=6.7850(4)Å c=19.6242(10)Å
α=90.00° β=106.444(5)° γ=90.00°
(2<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(6-methoxy-2-naphthyl)prop-2-en-1-one
C18H12Cl2O2S
Acta Crystallographica Section E (2010) 66, 7 o1717
a=7.3237(5)Å b=9.4919(6)Å c=22.4037(15)Å
α=90.00° β=96.1830(10)° γ=90.00°
(2E)-1-(2-Bromophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 7 o1661
a=12.7300(8)Å b=4.0061(3)Å c=13.0035(6)Å
α=90.00° β=100.671(5)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 7 o1638
a=5.7317(6)Å b=9.3920(7)Å c=23.6517(18)Å
α=90.00° β=91.231(8)° γ=90.00°
<i>N</i>'-[Bis(benzylsulfanyl)methylidene]-4-methoxybenzohydrazide
C23H22N2O2S2
Acta Crystallographica Section E (2010) 66, 8 o1899
a=9.838(2)Å b=9.845(2)Å c=11.307(2)Å
α=70.25(3)° β=90.00(3)° γ=89.37(3)°
(<i>E</i>)-1-(4-Bromophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 8 o1995
a=17.729(4)Å b=4.3505(9)Å c=19.335(4)Å
α=90.00° β=116.93(3)° γ=90.00°
(<i>E</i>)-1-(2-Bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one
C17H15BrO3
Acta Crystallographica Section E (2010) 66, 8 o1952
a=7.7643(9)Å b=9.7006(11)Å c=10.2722(10)Å
α=72.901(10)° β=78.487(9)° γ=86.359(9)°
1-[3,5-Bis(4-chlorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]ethanone
C17H14Cl2N2O
Acta Crystallographica Section E (2010) 66, 8 o1950-o1951
a=6.0716(9)Å b=13.160(2)Å c=19.782(3)Å
α=90.00° β=98.412(2)° γ=90.00°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-ethoxybenzaldehyde trihydrate
C17H16N2O3,3(H2O)
Acta Crystallographica Section E (2010) 66, 8 o2052
a=7.3020(15)Å b=9.3170(19)Å c=25.950(5)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-3-(4-Methoxyphenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C21H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1996
a=6.0963(11)Å b=10.985(2)Å c=13.133(3)Å
α=74.188(3)° β=88.674(3)° γ=77.393(3)°
3,5-Bis(4-fluorophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C21H16F2N2
Acta Crystallographica Section E (2010) 66, 8 o1948-o1949
a=12.2880(3)Å b=13.1678(3)Å c=11.3245(3)Å
α=90.00° β=112.661(3)° γ=90.00°